Pacific Biosciences of California Earnings: Here’s Why Investors are Excited Now

Pacific Biosciences of California, Inc. (NASDAQ:PACB) had a loss and beat Wall Street’s expectations, AND beat the revenue expectation. The revenue beat is a positive sign to shareholders seeking high growth out of the company. Shares are up 5.29%.

Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now!

Pacific Biosciences of California, Inc. Earnings Cheat Sheet

Results: Adjusted Earnings Per Share increased to $-0.37 in the quarter versus EPS of $-0.50 in the year-earlier quarter.

Revenue: Decreased 44.22% to $5.6 million from the year-earlier quarter.

Actual vs. Wall St. Expectations: Pacific Biosciences of California, Inc. reported adjusted EPS loss of $0.37 per share. By that measure, the company beat the mean analyst estimate of $-0.38. It beat the average revenue estimate of $5.29 million.

Quoting Management: There was no comment from the management.

Key Stats (on next page)…